Multicenter Evaluation of the Xpert Carba-R Assay for Detection and Identification of Carbapenemase Genes in Sputum Specimens

Zhen Cai, Tao Jia, Tianye Jia, Hongyu Fu, Xin Zhang, Mei Zhao, Hong Du, Hua Yu, Bin Shan, Bin Huang, Liang Chen, Yi‐Wei Tang, Wei Jia, Fen QuJournal of Clinical Microbiology 2020 · DOI

Abstract

Rapid diagnosis of infections caused by carbapenem-resistant <i>Enterobacteriaceae</i> (CRE) is crucial for proper treatment and infection control. The Xpert Carba-R assay is a qualitative multiplex real-time PCR method that qualitatively detects and differentiates five common carbapenemase genes (<i>bla</i><sub>KPC</sub>, <i>bla</i><sub>NDM</sub>, <i>bla</i><sub>VIM</sub>, <i>bla</i><sub>OXA-48</sub>, and <i>bla</i><sub>IMP</sub>) directly from rectal swabs or purified colonies within approximately 1 h. We performed a multicenter evaluation of the investigational use of the Carba-R assay for detection and differentiation of carbapenemase genes from sputum specimens in patients with a clinical diagnosis of pneumonia. The intra- and interassay coefficients of variation values for the Carba-R assay were 0.2% to 2.0% and 1.4% to 2.3%, respectively. A total of 301 sputum specimens were collected and tested. Compared to bacterial culture followed by PCR identification of resistance genes from colonies, the Carba-R assay reduced turnaround time from 56 to 84 h to less than 2 h. Carbapenemase genes were detected by the Carba-R assay in <i>Klebsiella pneumoniae</i> (<i>n</i> = 236), <i>Escherichia coli</i> (<i>n</i> = 22), <i>Enterobacter cloacae</i> (<i>n</i> = 23), <i>Klebsiella oxytoca</i> (<i>n</i> = 8), <i>Serratia marcescens</i> (<i>n</i> = 6), <i>Citrobacter freundii</i> (<i>n</i> = 4), and <i>Klebsiella aerogenes</i> (<i>n</i> = 2). The Carba-R assay detected 112 <i>bla</i><sub>KPC</sub> (33.5%), 70 <i>bla</i><sub>NDM</sub> (21.0%), 8 <i>bla</i><sub>IMP</sub> (2.4%), and 2 <i>bla</i><sub>VIM</sub> (0.6%) genes, with positive percent agreement, negative percent agreement, and concordance rates of 92.9%, 86.7%, and 88.3%, respectively, for the dominant <i>bla</i><sub>KPC</sub> and 85.0%, 87.8%, and 87.4%, respectively, for the <i>bla</i><sub>NDM</sub> genes. Neither method detected the <i>bla</i><sub>OXA-48</sub> carbapenemase gene. The convenient, rapid, and simple characteristics of the Xpert Carba-R assay make it a potential tool for CRE detection and identification directly in sputum specimens.
BibTeX
@article{cai2020multicenter,
  author = {Zhen Cai and Tao Jia and Tianye Jia and Hongyu Fu and Xin Zhang and Mei Zhao and Hong Du and Hua Yu and Bin Shan and Bin Huang and Liang Chen and Yi‐Wei Tang and Wei Jia and Fen Qu},
  title = {{Multicenter Evaluation of the Xpert Carba-R Assay for Detection and Identification of Carbapenemase Genes in Sputum Specimens}},
  journal = {Journal of Clinical Microbiology},
  year = {2020},
  doi = {10.1128/jcm.00644-20},
}

Loading related content...

Figure